|
1
|
Wistuba II: Genetics of preneoplasia:
Lessons from lung cancer. Curr Mol Med. 7:3–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Verdecchia A, Francisci S, Brenner H,
Gatta G, Micheli A, Mangone L and Kunkler I; EUROCARE-4 Working
Group: Recent cancer survival in Europe: A 2000–02 period analysis
of EUROCARE-4 data. Lancet Oncol. 8:784–796. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Klebe S and Henderson DW: Facts and
fiction: Premalignant lesions of lung tissues. Pathology.
45:305–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W and Schlesinger
F: Landscape of transcription in human cells. Nature. 489:101–108.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gadgeel SM, Cote ML, Schwartz AG, Matherly
LH, Wozniak A and Bepler G: Parameters for individualizing systemic
therapy in non-small cell lung cancer. Drug Resist Updat.
13:196–204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Birney E, Stamatoyannopoulos JA, Dutta A,
Guigó R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis
ET and Thurman RE: Children′s Hospital Oakland Research Institute:
Identification and analysis of functional elements in 1% of the
human genome by the ENCODE pilot project. Nature. 447:799–816.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ponting CP and Belgard TG: Transcribed
dark matter: Meaning or myth? Hum Mol Genet. 19:R162–R168. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Inamura K: Major tumor suppressor and
oncogenic non-coding RNAs: Clinical relevance in lung cancer.
Cells. 6:62017. View Article : Google Scholar
|
|
9
|
Shi T, Gao G and Cao Y: Long noncoding
RNAs as novel biomarkers have a promising future in cancer
diagnostics. Dis Markers. 2016:90851952016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fatima R, Akhade VS, Pal D and Rao SM:
Long noncoding RNAs in development and cancer: Potential biomarkers
and therapeutic targets. Mol Cell Ther. 3:52015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gayen S, Maclary E, Buttigieg E, Hinten M
and Kalantry S: A primary role for the Tsix lncRNA in maintaining
random X-chromosome inactivation. Cell Reports. 11:1251–1265. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kawaguchi T and Hirose T: Chromatin
remodeling complexes in the assembly of long noncoding
RNA-dependent nuclear bodies. Nucleus. 6:462–467. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhuang W, Ge X, Yang S, Huang M, Zhuang W,
Chen P, Zhang X, Fu J, Qu J and Li B: Upregulation of lncRNA MEG3
promotes osteogenic differentiation of mesenchymal stem cells from
multiple myeloma patients by targeting BMP4 transcription. Stem
Cells. 33:1985–1997. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmidt LH, Spieker T, Koschmieder S,
Schäffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D and
Marra A: The long noncoding MALAT-1 RNA indicates a poor prognosis
in non-small cell lung cancer and induces migration and tumor
growth. J Thorac Oncol. 6:1984–1992. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee YS and Dutta A: MicroRNAs: Small but
potent oncogenes or tumor suppressors. Curr Opin Investig Drugs.
7:560–564. 2006.PubMed/NCBI
|
|
16
|
Zhang E, Li W, Yin D, De W, Zhu L, Sun S
and Han L: c-Myc-regulated long non-coding RNA H19 indicates a poor
prognosis and affects cell proliferation in non-small-cell lung
cancer. Tumour Biol. 37:4007–4015. 2016. View Article : Google Scholar
|
|
17
|
Sadiq AA and Salgia R: MET as a possible
target for non-small-cell lung cancer. J Clin Oncol. 31:1089–1096.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matouk IJ, Raveh E, Abu-lail R, Mezan S,
Gilon M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M,
et al: Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys
Acta. 1843:1414–1426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zaleska K: miRNA - Therapeutic tool in
breast cancer? Where are we now? Rep Pract Oncol Radiother.
20:79–86. 2014. View Article : Google Scholar
|
|
21
|
Zhou W, Ye XL, Xu J, Cao MG, Fang ZY, Li
LY, Guan GH, Liu Q, Qian YH and Xie D: The lncRNA H19 mediates
breast cancer cell plasticity during EMT and MET plasticity by
differentially sponging miR-200b/c and let-7b. Sci Signal.
10:102017. View Article : Google Scholar
|
|
22
|
Lv M, Zhong Z, Huang M, Tian Q, Jiang R
and Chen J: lncRNA H19 regulates epithelial-mesenchymal transition
and metastasis of bladder cancer by miR-29b3p as competing
endogenous RNA. Biochim Biophys Acta Mol Cell Res. 1864:1887–1899.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Avasarala S, Van Scoyk M, Wang J, Sechler
M, Vandervest K, Brzezinski C, Weekes C, Edwards MG, Arcaroli J,
Davis RE, et al: hsa-miR29b, a critical downstream target of
non-canonical Wnt signaling, plays an anti-proliferative role in
non-small cell lung cancer cells via targeting MDM2 expression.
Biol Open. 2:675–685. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weerasinghe P, Garcia GE, Zhu Q, Yuan P,
Feng L, Mao L and Jing N: Inhibition of Stat3 activation and tumor
growth suppression of non-small cell lung cancer by G-quartet
oligonucleotides. Int J Oncol. 31:129–136. 2007.PubMed/NCBI
|
|
25
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar
|
|
26
|
Shin C, Nam JW, Farh KK, Chiang HR,
Shkumatava A and Bartel DP: Expanding the microRNA targeting code:
Functional sites with centered pairing. Mol Cell. 38:789–802. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Karginov FV, Cheloufi S, Chong MM, Stark
A, Smith AD and Hannon GJ: Diverse endonucleolytic cleavage sites
in the mammalian transcriptome depend upon microRNAs, Drosha, and
additional nucleases. Mol Cell. 38:781–788. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Inamura K: Lung Cancer: Understanding Its
Molecular Pathology and the 2015. WHO Classification Front Oncol.
7:1932017. View Article : Google Scholar
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
30
|
Chung WJ, Agius P, Westholm JO, Chen M,
Okamura K, Robine N, Leslie CS and Lai EC: Computational and
experimental identification of mirtrons in. Drosophila melanogaster
and Caenorhabditis elegans Genome Res. 21:286–300. 2011.
|
|
31
|
Lee I, Ajay SS, Yook JI, Kim HS, Hong SH,
Kim NH, Dhanasekaran SM, Chinnaiyan AM and Athey BD: New class of
microRNA targets containing simultaneous 5′-UTR and 3′-UTR
interaction sites. Genome Res. 19:1175–1183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Farh KK, Grimson A, Jan C, Lewis BP,
Johnston WK, Lim LP, Burge CB and Bartel DP: The widespread impact
of mammalian MicroRNAs on mRNA repression and evolution. Science.
310:1817–1821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saito M, Shiraishi K, Matsumoto K,
Schetter A, Ogata-Kawata H, Tsuchiya N, Kunitoh H, Nokihara H,
Watanabe S, Tsuta K, et al: A three-microRNA signature predicts
responses to platinum-based doublet chemotherapy in patients with
lung adenocarcinoma. Clin Cancer Res. 20:4784–4793. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang Y, Li H, Hou S, Hu B, Liu J and Wang
J: The noncoding RNA expression profile and the effect of lncRNA
AK126698 on cisplatin resistance in non-small-cell lung cancer
cell. PLoS One. 8:e653092013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bartolomei MS, Zemel S and Tilghman SM:
Parental imprinting of the mouse H19 gene. Nature. 351:153–155.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tabano S, Colapietro P, Cetin I, Grati FR,
Zanutto S, Mandò C, Antonazzo P, Pileri P, Rossella F, Larizza L,
et al: Epigenetic modulation of the IGF2/H19 imprinted domain in
human embryonic and extra-embryonic compartments and its possible
role in fetal growth restriction. Epigenetics. 5:313–324. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Byun HM, Wong HL, Birnstein EA, Wolff EM,
Liang G and Yang AS: Examination of IGF2 and H19 loss of imprinting
in bladder cancer. Cancer Res. 67:10753–10758. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Berteaux N, Lottin S, Monté D, Pinte S,
Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T and
Adriaenssens E: H19 mRNA-like noncoding RNA promotes breast cancer
cell proliferation through positive control by E2F1. J Biol Chem.
280:29625–29636. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cui J, Mo J, Luo M, Yu Q, Zhou S, Li T,
Zhang Y and Luo W: c-Myc-activated long non-coding RNA H19
downregulates miR-107 and promotes cell cycle progression of
non-small cell lung cancer. Int J Clin Exp Pathol. 8:12400–12409.
2015.
|
|
40
|
Wang Q, Cheng N, Li X, Pan H, Li C, Ren S,
Su C, Cai W, Zhao C, Zhang L, et al: Correlation of long non-coding
RNA H19 expression with cisplatin-resistance and clinical outcome
in lung adenocarcinoma. Oncotarget. 8:2558–2567. 2017.
|
|
41
|
Hu Q, Wang YB, Zeng P, Yan GQ, Xin L and
Hu XY: Expression of long non-coding RNA (lncRNA) H19 in
immunodeficient mice induced with human colon cancer cells. Eur Rev
Med Pharmacol Sci. 20:4880–4884. 2016.PubMed/NCBI
|
|
42
|
Kallen AN, Zhou XB, Xu J, Qiao C, Ma J,
Yan L, Lu L, Liu C, Yi JS, Zhang H, et al: The imprinted H19 lncRNA
antagonizes let-7 microRNAs. Mol Cell. 52:101–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y,
Jia WH and Zhuang SM: Effects of microRNA-29 on apoptosis,
tumorigenicity, and prognosis of hepatocellular carcinoma.
Hepatology. 51:836–845. 2010.
|
|
44
|
Yan B, Guo Q, Nan XX, Wang Z, Yin Z, Yi L,
Wei YB, Gao YL, Zhou KQ and Yang JR: Micro-ribonucleic acid 29b
inhibits cell proliferation and invasion and enhances cell
apoptosis and chemotherapy effects of cisplatin via targeting of
DNMT3b and AKT3 in prostate cancer. Onco Targets Ther. 8:557–565.
2015.PubMed/NCBI
|
|
45
|
Wang H, Guan X, Tu Y, Zheng S, Long J, Li
S, Qi C, Xie X, Zhang H, Zhang Y, et al: MicroRNA-29b attenuates
non-small cell lung cancer metastasis by targeting matrix
metalloproteinase 2 and PTEN. J Exp Clin Cancer Res. 34:592015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhao X, Liu Y, Li Z, Zheng S, Wang Z, Li
W, Bi Z, Li L, Jiang Y, Luo Y, et al: Linc00511 acts as a competing
endogenous RNA to regulate VEGFA expression through sponging
hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. J Cell Mol Med.
22:655–667. 2018. View Article : Google Scholar
|
|
47
|
Ko HJ and Kim YJ: Signal transducer and
activator of transcription proteins: Regulators of myeloid-derived
suppressor cell-mediated immunosuppression in cancer. Arch Pharm
Res. 39:1597–1608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signalling in cancer: New and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Calò V, Migliavacca M, Bazan V, Macaluso
M, Buscemi M, Gebbia N and Russo A: STAT proteins: From normal
control of cellular events to tumorigenesis. J Cell Physiol.
197:157–168. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Siveen KS, Sikka S, Surana R, Dai X, Zhang
J, Kumar AP, Tan BK, Sethi G and Bishayee A: Targeting the STAT3
signaling pathway in cancer: Role of synthetic and natural
inhibitors. Biochim Biophys Acta. 1845:136–154. 2014.PubMed/NCBI
|
|
51
|
Zhang P, Sun Y and Ma L: ZEB1: At the
crossroads of epithelial- mesenchymal transition, metastasis and
therapy resistance. Cell Cycle. 14:481–487. 2015. View Article : Google Scholar :
|
